5661 DAN (Sulindac 150 mg)

Pill imprint 5661 DAN has been identified as Sulindac 150 mg.

Sulindac is used in the treatment of pain; osteoarthritis; ankylosing spondylitis; gout, acute; familial adenomatous polyposis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 5661 DAN

Sulindac 150 mg 5661 DAN
Sulindac 150 mg 5661 DAN Front
Sulindac 150 mg 5661 DAN Back
Sulindac 150 mg 5661 DAN
Sulindac
Imprint:
5661
DAN
Strength:
150 mg
Color:
Yellow
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-5661
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
stearic acid
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
66267-0264 Nucare Pharmaceuticals Inc (repackager)
54868-0879 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)